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190 Ventilation inhomogeneity in patients with cystic ﬁbrosis aged
10−18 years
U. Pradal1, A. Borruso1, L. Menin1, E. Fedrigo1, B.M. Assael1. 1Azienda
Ospedaliera Universitaria Integrata Verona, Cystic Fibrosis Center, Verona, Italy
Spirometry is used to detect and monitor airway disease in CF but its normality
cannot rule out the presence of early lung function abnormalities due to the
obstruction of peripheral airways. The Lung Clearance Index (LCI), a measure of
ventilation inhomogeneity, is used to detect early functional damage in infants and
children with CF. Over the years life expectancy and lung disease control improved
signiﬁcantly in CF, such that at present an increasing number of patients reach
adulthood with a normal spirometry. Aim of the present study was to understand if
ventilation inhomogeneity is a common ﬁnding in these patients.
60 CF patients with FEV1 >40%pred (30 males) aged 10−18 years were studied.
Spirometry and whole body plethysmography were performed according to standard
procedures. LCI was measured by Helium rebreathing in a water sealed spirometer
with continuous CO2 removal and O2 supply in all patients and a group of healthy
controls.
LCI values were signiﬁcantly correlated with the measured lung function param-
eters, i.e. FEV1%pred (p< 0.0001), FEF25−75%pred (p< 0.0001) and FRC/TLC
(p = 0.0008).
High LCI values were found in 41/60 patients (68%). Airway obstruction was
less common (FEV1 was abnormal in 14 patients, 23%). It is remarcable that
27/46 patients (59%) with normal FEV1, 23/38 (60%) with normal FEF25−75 and
14/24 (58%) with normal FRC/TLC had elevated LCI values.
These results suggest that ventilation inhomogeneity is common in CF patients
10−18 years old. In most cases common methods to study lung function fail to
identify CF patients with airway damage thus leading to a possible delay in treating
the disease.
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Objectives: Cystic ﬁbrosis is characterised by airway obstruction. Reactance at 5Hz
(X5) measured by impulse oscillometry (IOS) determines the capacitive properties
of the peripheral lung. Resistance measurements are frequency independent in health
but in peripheral airway obstruction, resistance at 5Hz (R5) is raised. IOS is quick,
easy to perform and correlates with spirometry. It has a linear relationship with
residual volume/total lung capacity ratio (RV/TLC). The aim of this study was
to assess the relationship of IOS parameters with gas trapping measured on high
resolution CT thorax (HRCT).
Methods: IOS, spirometry and plethysmography were performed in 24 adult
patients with CF (17−56 years, FEV1 26–119% of predicted). Two radiologists
independently scored percentage gas trapping to the nearest 5% on HRCT scans.
These scores were correlated with the physiological measurements.
Results: There was a strong inverse linear relationship evident between X5
and RV/TLC (r = −0.82, p< 0.01) and CT gas trapping (r = −0.65, p< 0.01). X5
correlated with FEV1 (r = 0.90, p< 0.01), but the relationship was not linear. R5
correlated with FEV1 (r = −0.73, p< 0.01) and CT gas trapping (r = 0.57, p< 0.01)
but not RV/TLC (r = 0.47).
Conclusion: These results suggest X5 could be used as a convenient method
to measure gas trapping in CF adults and may give as much information as
plethysmography. The linear relationship with gas trapping indices and X5, which
is not present at lower FEV1 values, indicates X5 should be considered a potentially
useful marker in severe CF lung disease.
192 Volumetric capnography is correlated with spirometry in cystic
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Objectives: To compare and to correlate volumetric capnography (Vcap) and
spirometry to evaluate cystic ﬁbrosis (CF) pulmonary function.
Methods: A cross sectional study including a cohort of 58 CFpatients (31 female) at
a University Reference Center of CF in 2012. All of them were evaluated with Vcap
(CO2MOplus, Novametrix) and spirometry (CPFS/D, MedGraphics). The patients
were out of pulmonary exacerbation. The median age was 14 years (9−24) and
BMI 17.3.
Of the 58 patients 16 (27.6%) had normal and 42 (72.4%) abnormal spirometry.
When comparing the groups with normal and abnormal spirometry (Mann-Whitney
test) there was a signiﬁcant difference in the Vcap phase 3 slope (P3Slp) (p = 0.001)
and pulse (p = 0.048). In addition, there was a strong negative correlation between
FEV1 and P3Slp (p< 0.01, r = −0.714).
Conclusion: Vcap is a quick and simple tidal breathing test and it is feasible to
evaluate lung pulmonary disease in CF patients. P3Slp was correlated with FEV1.
The method has the potential to be introduced as a screening tool into clinical
routine. Vcap requires further evaluation before this technique can be recommended
for monitoring CF lung disease.
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Introduction: Tobramycine for inhalation is an established treatment for patients
with CF and Pseudomonas aeruginosa infection. However, it is expensive and in
many countries reimbursement is limited. Therefore, tobramycin solution for iv
administration, is often used as an alternative.
Study objective: To examine the inﬂuence of Obracin® (O) versus Tobi® (T) on
ciliary beat frequency (CBF) in an in vitro respiratory epithelial cell model.
Methods: We have previously constructed and validated a model for evaluation of
nebulized drugs on CBF. Nasal epithelial cells were derived from non-CF surgery
specimens and cultured as a monolayer. Evolution of CBF was expressed as % of
the baseline value. Changes in CBF induced by nebulization with O (160mg/4ml),
T (300mg/4ml) and isotonic saline (S) as control condition were measured and
compared with mixed model analysis. Three samples of 3 different patients were
exposed to nebulization of either T, O or S, on 3 consecutive days.
Results: Nebulization with O resulted in a signiﬁcant decrease of CBF compared
to nebulization with T (p 0.0001), even in a lower concentration of tobramycin.
This was also true on each separate day (p 0.046 for day 1, p 0.026 for day 2 and
p 0.008 for day 3). One hour after nebulization with O, CBF decreased to 59%
of baseline (p< 0.0001), compared to 92% after nebulization with T (p 0.116) and
97% after nebulization with S (p 0.536). This inhibitory effect of O on CBF is
possibly caused by additives in the parenteral solution.
Conclusion: Nebulisation of Obracin® impairs ciliary activity in vitro. Therefore,
it may be advisable to prefer Tobi® in patients with CF or non-CF bronchiectasis.
